Skip to main content
Kane Biotech Inc. logo

Kane Biotech Inc. — Investor Relations & Filings

Ticker · KNE ISIN · CA4838092084 TSXV Manufacturing
Open in API
Filings indexed 582 across all filing types
Latest filing 2023-03-24 AGM Information
Country CA Canada
Listing TSXV KNE

About Kane Biotech Inc.

https://kanebiotech.com/

Kane Biotech Inc. is a biotechnology company engaged in the research, development, and commercialization of proprietary technologies designed to prevent and remove microbial biofilms, which are a major contributor to chronic infections and impaired healing. The company holds extensive intellectual property related to biofilm formation and dispersal mechanisms, utilizing proprietary technologies such as DispersinB® and coactiv+®. Its primary commercial focus is advanced wound care, where products like the revyve® Antimicrobial Wound Gel and Spray are designed to disrupt biofilms and promote healing. The product pipeline also includes surgical and dermatological applications for both human and animal health.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a notice and access notification for the 2023 Annual Meeting of Shareholders of Bombardier Inc. It provides details about the meeting date, time, location (webcast), business to be conducted, record date for shareholders entitled to vote, and instructions on how to access the meeting materials online. It also mentions the availability of the management proxy circular and the 2022 financial report but does not contain the actual financial statements or detailed reports. The document is primarily an announcement and invitation to the AGM and instructions for shareholders to access materials and vote. It does not contain the full annual report, proxy statement, or voting results. Therefore, it fits the category of AGM Information (AGM-R) as it relates to the Annual General Meeting and the materials shared or made available for it.
2023-03-24 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 95% confidence The document is a confirmation notice from TSX Trust Company regarding the record and meeting dates for Kane Biotech Inc.'s upcoming Annual and Special Meeting of Security Holders. It includes details such as the meeting date, record date, classes of securities entitled to vote, and proxy-related material delivery information. The document does not contain any financial data, management discussion, or detailed report content. It is a formal announcement related to shareholder meeting logistics rather than the meeting materials themselves or voting results. Given the nature and length of the document (1904 characters), it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories like AGM Information or Declaration of Voting Results.
2023-03-24 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a change in the terms of a credit facility, specifically an increase in the interest rate from 14% to 15%. It references an amending agreement dated March 2, 2023, and previous announcements. The content focuses on financing terms and does not contain financial statements or detailed financial performance data. The document length is 3685 characters, which is relatively short and typical for an announcement rather than a full report. There is no indication that this is a full financial report, audit, or earnings release. The nature of the announcement is clearly related to financing activities, specifically credit facility terms. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-03-04 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing a Letter of Intent (LOI) for a business combination between Uravan Minerals Inc. and Nuclear Fuels Inc. It details the proposed transaction terms, including share exchange, share consolidation, management changes, and listing changes. The document is not a full financial report but an announcement of a merger-related transaction. It includes forward-looking statements and cautionary notes typical of merger announcements. There is no detailed financial data or comprehensive financial statements. The document fits the category of M&A Activity announcements rather than a full merger filing or proxy statement. Therefore, the appropriate classification is 'TAR' (M&A Activity). The document length (12,603 characters) supports it being a substantive announcement rather than a brief notice or regulatory filing. Confidence is high given the clear content and context.
2023-03-02 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing proposed amendments to the company's credit facility, including an increase in the credit limit and extension of the maturity date, as well as changes to the board of directors with resignations accepted. It does not contain financial statements or detailed financial data, nor is it a full report. The content focuses on financing updates and management changes. Given the dual nature of the announcement (credit facility amendment and board changes), the primary focus is on the financing update. The document length is 4206 characters, which is relatively short and typical for an announcement rather than a full report. Therefore, the classification aligns best with Capital/Financing Update (CAP) due to the credit facility amendment announcement. The board changes could suggest MANG, but since the credit facility amendment is the headline and main content, CAP is more appropriate.
2023-03-01 English
News release - English.pdf
Regulatory Filings
2023-02-06 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.